Optimization of Movement Patterns in Elite Volleyball Players

Completed

• Conditions: Optimisation of Performance and Avoidance of Injury
• Interventions: Other: advise for exercices given by team staff

• Registration Number: NCT02554461
• Lead Sponsor: Prof. Dr. F. Staes

Brief Summary

On the basis of clinical and movement analysis records players are informed on what parameters can be optimized in order to improve their performance and avoid injuries

Detailed Description

Not available

Study Timeline

• Study Start: 2015-08
• Study First Submitted: 2015-09-16
• Study First Submitted QC: 2015-09-16
• Study First Posted: 2015-09-18
• Status Verified: 2016-10
• Primary Completion: 2016-12
• Study Completion: 2017-03
• Last Update Submitted: 2017-05-01
• Last Update Posted: 2017-05-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Members of national volleyball team signing informed consent

Exclusion Criteria

No specific exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
female players	advise for exercices given by team staff	national team players
male players	advise for exercices given by team staff	national team players

Primary Outcome Measures

Name	Time	Method
2D and 3D joint angles of different movements together with kinetics	1 day	kinematics and kinetics with regard to gait, running, jumping and arm movements. This means for example joint angles (measured by 3D motion analyses data, 2D measurement data) and kinetics (joint moments, pressure plate measurements) Time frames: these data will recorded by one measurement session. For information of clinicaltrials.gov (also other outcome measures): at this point it really is an observational study. It is a kind of "service project" for an elite athletes team. Advice is provided, but not as is meant within a real clinical trial. It might evolve to such a project, but at this state it is not the case.

Secondary Outcome Measures

Name	Time	Method
(segmental) length	1 day	Meter
joint stability	1 day	nominal scale (good, poor)
joint control	1 day	nominal scale (good, poor)
prevalence injury past	1 day	interview (frequency/percentage of occurrence)
weight	1 day	Kg
muscle strength	1 day	isokinetic measurements (ratio agonist/antagonist as for example ratio between knee flexors/extensors) Time frames: these data will be recorded during one measurement session. This is during same session as for primary outcome measure.
Body mass index	1 day	Kg/m²
prevalence injury present	1 day	interview (yes/no)

Trial Locations

Locations (1)

KU Leuven/UZLeuven; 🇧🇪 Leuven, Vlaams-Brabant, Belgium